Takara Bio Inc
TSE:4974
Takara Bio Inc
Cost of Revenue
Takara Bio Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takara Bio Inc
TSE:4974
|
Cost of Revenue
-¥16.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
GNI Group Ltd
TSE:2160
|
Cost of Revenue
-¥3.6B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-36%
|
|
PeptiDream Inc
TSE:4587
|
Cost of Revenue
-¥11.5B
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Cost of Revenue
-¥13.1B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-35%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cost of Revenue
-¥823.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-4%
|
S
|
StemRIM Inc
TSE:4599
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takara Bio Inc's Cost of Revenue?
Cost of Revenue
-16.6B
JPY
Based on the financial report for Mar 31, 2024, Takara Bio Inc's Cost of Revenue amounts to -16.6B JPY.
What is Takara Bio Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%
Over the last year, the Cost of Revenue growth was 50%. The average annual Cost of Revenue growth rates for Takara Bio Inc have been -5% over the past three years , -2% over the past five years , and -4% over the past ten years .